EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Defining borderline resectability in pancreatic neuroendocrine tumors and the role of neoadjuvant therapy

Wilson M Alobuia, Susan Tsai, Mary Dillhoff, Timothy M Pawlik, Alex B Blair, Vineeth Sukrithan, Bhavana Konda, Jordan M Cloyd

HPB · 2026-11 · 28 (11) · 1517-1529

DOI: 10.1016/j.hpb.2026.08.2006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HPB, 2026-11. Verfasst von Wilson M Alobuia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology and Hepatobiliary Surgery, New York University Grossman School of Medicine, New York, United Sta…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Pancreatic Neoplasms, Neuroendocrine Tumors, Pancreatectomy. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyPancreatic NeoplasmsNeuroendocrine TumorsPancreatectomyHumansFemaleTreatment OutcomeMaleMiddle AgedTime FactorsRisk FactorsNeoplasm StagingDatabases, FactualAgedKaplan-Meier EstimateRetrospective StudiesProportional Hazards ModelsUnited StatesMultivariate AnalysisChemotherapy, AdjuvantAdultPatient Selection

Autor:innen und Institutionen

  • Department of Surgery, Division of Surgical Oncology and Hepatobiliary Surgery, New York University Grossman School of Medicine, New York, United States.
  • Department of Surgery, Division of Surgical Oncology and Hepatobiliary Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
  • Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States.
  • Department of Surgery, Division of Surgical Oncology and Hepatobiliary Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States. Electronic address: jordan.cloyd@osumc.edu.

Zitieren

APA

Alobuia, W. M., Tsai, S., Dillhoff, M., Pawlik, T. M., Blair, A. B., Sukrithan, V., Konda, B., & Cloyd, J. M. (2026). Defining borderline resectability in pancreatic neuroendocrine tumors and the role of neoadjuvant therapy. HPB, 28(11), 1517-1529. https://doi.org/10.1016/j.hpb.2026.08.2006

Vancouver

Alobuia WM, Tsai S, Dillhoff M, Pawlik TM, Blair AB, Sukrithan V, et al. Defining borderline resectability in pancreatic neuroendocrine tumors and the role of neoadjuvant therapy. HPB. 2026;28(11):1517-1529. doi:10.1016/j.hpb.2026.08.2006

BibTeX
@article{Alobuia2026,
  author = {Alobuia, Wilson M and Tsai, Susan and Dillhoff, Mary and Pawlik, Timothy M and Blair, Alex B and Sukrithan, Vineeth and Konda, Bhavana and Cloyd, Jordan M},
  title = {Defining borderline resectability in pancreatic neuroendocrine tumors and the role of neoadjuvant therapy},
  journal = {HPB},
  year = {2026},
  volume = {28},
  number = {11},
  pages = {1517--1529},
  doi = {10.1016/j.hpb.2026.08.2006}
}
Kostenlos starten →